Role of fibroblast growth factors in organ regeneration and repair

Seminars in Cell and Developmental Biology

Volumn 53, Issue , 2016, Pages 76-84

  El Agha, Elie ^a   Kosanovic, Djuro ^a   Schermuly, Ralph T ^a   Bellusci, Saverio ^a,b  

^a JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^b KAZAN FEDERAL UNIVERSITY   (Russian Federation)

Author keywords

Fibroblast growth factors; Homeostatic balance; Organogenesis; Regeneration; Repair

Indexed keywords

FIBROBLAST GROWTH FACTOR; MITOGENIC AGENT; MORPHOGEN; RECOMBINANT FIBROBLAST GROWTH FACTOR; RECOMBINANT PROTEIN;

CELL RENEWAL; EMBRYO DEVELOPMENT; HOMEOSTASIS; HUMAN; LIMB REGENERATION; NONHUMAN; POSTNATAL DEVELOPMENT; REVIEW; SALAMANDER; SIGNAL TRANSDUCTION; TISSUE REGENERATION; TISSUE REPAIR; VERTEBRATE; ANIMAL; ANTIBODY SPECIFICITY; DRUG EFFECTS; REGENERATION; WOUND HEALING;

ANIMALS; FIBROBLAST GROWTH FACTORS; HUMANS; ORGAN SPECIFICITY; RECOMBINANT PROTEINS; REGENERATION; WOUND HEALING;

EID: 84951170385     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2015.10.009     Document Type: Review

References (162)

1. Armelin H.A. Pituitary extracts and steroid hormones in the control of 3T3 cell growth. Proc. Natl. Acad. Sci. U.S.A. 1973, 70:2702-2706.
2. Thomas K.A., Rios-Candelore M., Fitzpatrick S. Purification and characterization of acidic fibroblast growth factor from bovine brain. Proc. Natl. Acad. Sci. U.S.A. 1984, 81:357-361.
3. Gospodarowicz D., Bialecki H., Greenburg G. Purification of the fibroblast growth factor activity from bovine brain. J. Biol. Chem. 1978, 253:3736-3743.
4. Gospodarowicz D. Purification of a fibroblast growth factor from bovine pituitary. J. Biol. Chem. 1975, 250:2515-2520.
5. Palmiter R.D., Brinster R.L. Germ-line transformation of mice. Annu. Rev. Genet. 1986, 20:465-499. 10.1146/annurev.genet.20.1.465.
6. Hanahan D., Wagner E.F., Palmiter R.D. The origins of oncomice: a history of the first transgenic mice genetically engineered to develop cancer. Genes Dev. 2007, 21:2258-2270. 10.1101/gad.1583307.
7. Ornitz D.M., Itoh N. Protein family review Fibroblast growth factors Gene organization and evolutionary history. Genome Biol. 2001, 2:1-12. 10.1186/gb-2001-2-3-reviews3005.
8. Itoh N., Ornitz D.M. Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease. J. Biochem. 2011, 149:121-130. mvq121 (pii). 10.1093/jb/mvq121.
9. Shimada T., Hasegawa H., Yamazaki Y., Muto T., Hino R., Takeuchi Y., et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J. Bone Min. Res. 2004, 19:429-435. 10.1359/JBMR. 0301264.
10. Urakawa I., Yamazaki Y., Shimada T., Iijima K., Hasegawa H., Okawa K., et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 2006, 444:770-774. nature05315 (pii). 10.1038/nature05315.
11. Kurosu H., Choi M., Ogawa Y., Dickson A.S., Goetz R., Eliseenkova A.V., et al. Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. J Biol Chem 2007, 282:26687-26695. M704165200 (pii). 10.1074/jbc.M704165200.
12. Hotta Y., Nakamura H., Konishi M., Murata Y., Takagi H., Matsumura S., et al. Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver. Endocrinology 2009, 150:4625-4633. en.2009-0119 (pii). 10.1210/en.2009-0119.
13. Adams A.C., Coskun T., Rovira A.R.I., Schneider M.A., Raches D.W., Micanovic R., et al. Fundamentals of FGF19 & FGF21 action in vitro and in vivo. PLoS ONE 2012, 7:e38438. 10.1371/journal.pone.0038438.
14. Kharitonenkov A., Adams A.C. Inventing new medicines: the FGF21 story. Mol. Metab. 2014, 3:221-229. 10.1016/j.molmet.2013.12.003.
15. Goldfarb M., Schoorlemmer J., Williams A., Diwakar S., Wang Q., Huang X., et al. Fibroblast growth factor homologous factors control neuronal excitability through modulation of voltage-gated sodium channels. Neuron 2007, 55:449-463. S0896-6273(07)00525-9 (pii). 10.1016/j.neuron.2007.07.006.
16. Shakkottai V.G., Xiao M., Xu L., Wong M., Nerbonne J.M., Ornitz D.M., et al. FGF14 regulates the intrinsic excitability of cerebellar Purkinje neurons. Neurobiol. Dis. 2009, 33:81-88. doi:S0969-9961(08)00227-1 [pii] 10.1016/j.nbd.2008.09.019.
17. Itoh N., Ornitz D.M. Evolution of the Fgf and Fgfr gene families. Trends Genet. 2004, 20:563-569. S0168-9525(04)00241-0 (pii). 10.1016/j.tig.2004.08.007.
18. Itoh N., Ornitz D.M. Functional evolutionary history of the mouse Fgf gene family. Dev. Dyn. 2008, 237:18-27. 10.1002/dvdy.21388.
19. Beenken A., Mohammadi M. The FGF family: biology, pathophysiology and therapy. Nat. Rev. Drug Discov. 2009, 8:235-253. nrd2792 (pii). 10.1038/nrd2792.
20. Goetz R., Mohammadi M. Exploring mechanisms of FGF signalling through the lens of structural biology. Nat. Rev. Mol. Cell Biol. 2013, 14:166-180. 10.1038/nrm3528.
21. Belov A.A., Mohammadi M. Molecular mechanisms of fibroblast growth factor signaling in physiology and pathology. Cold Spring Harb. Perspect. Biol. 2013, 5. 10.1101/cshperspect.a015958.
22. McKeehan W.L., Wang F., Kan M. The heparan sulfate-fibroblast growth factor family: diversity of structure and function. Prog. Nucleic Acid Res. Mol. Biol. 1998, 59:135-176.
23. Ornitz D.M., Itoh N. The Fibroblast Growth Factor signaling pathway. Wiley Interdiscip. Rev. Dev. Biol. 2015, 10.1002/wdev.176.
24. Buntrock P., Jentzsch K.D., Heder G. Stimulation of wound healing, using brain extract with fibroblast growth factor (FGF) activity. I. Quantitative and biochemical studies into formation of granulation tissue. Exp. Pathol. 1982, 21:46-53.
25. Greenhalgh D.G., Sprugel K.H., Murray M.J., Ross R. PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am. J. Pathol. 1990, 136:1235-1246.
26. Woost P.G., Brightwell J., Eiferman R.A., Schultz G.S. Effect of growth factors with dexamethasone on healing of rabbit corneal stromal incisions. Exp. Eye Res. 1985, 40:47-60.
27. Courtois Y., Grandjean M., Courty J., Barritault D., Pouliquen Y. Effects of the growth factors EDGF I and EDGF II on wound healing of the corneal epithelium in rabbits. C. R. Seances Soc. Biol. Fil. 1987, 181:491-494.
28. Cuevas P., Burgos J., Baird A. Basic fibroblast growth factor (FGF) promotes cartilage repair in vivo. Biochem. Biophys. Res. Commun. 1988, 156:611-618. 10.1016/S0006-291X(88)80887-8.
29. Fukasawa M., Yanagihara D.L., Rodgers K.E., DiZerega G.S. The mitogenic activity of peritoneal tissue repair cells: control by growth factors. J. Surg. Res. 1989, 47:45-51.
30. Aebischer P., Salessiotis A.N., Winn S.R. Basic fibroblast growth factor released from synthetic guidance channels facilitates peripheral nerve regeneration across long nerve gaps. J. Neurosci. Res. 1989, 23:282-289. 10.1002/jnr.490230306.
31. Reidy M.A., Jackson C.L. Factors controlling growth of arterial cells following injury. Toxicol. Pathol. 1990, 18:547-553.
32. Armstrong R., Friedrich V.L., Holmes K.V., Dubois-Dalcq M. In vitro analysis of the oligodendrocyte lineage in mice during demyelination and remyelination. J. Cell Biol. 1990, 111:1183-1195.
33. Gómez-Pinilla F., Lee J.W., Cotman C.W., Basic F.G.F. in adult rat brain: cellular distribution and response to entorhinal lesion and fimbria-fornix transection. J. Neurosci. 1992, 12:345-355.
34. Fina M., Bresnick S., Baird A., Ryan A. Improved healing of tympanic membrane perforations with basic fibroblast growth factor. Growth Factors 1991, 5:265-272.
35. Anderson J.E., Liu L., Kardami E. Distinctive patterns of basic fibroblast growth factor (bFGF) distribution in degenerating and regenerating areas of dystrophic (mdx) striated muscles. Dev. Biol. 1991, 147:96-109.
36. Folkman J., Szabo S., Stovroff M., McNeil P., Li W., Shing Y. Duodenal ulcer. Discovery of a new mechanism and development of angiogenic therapy that accelerates healing. Ann. Surg. 1991, 214:414-425. (discussion 426-427).
37. Okazaki Y., Kagami H., Hattori T., Hishida S., Shigetomi T., Ueda M. Acceleration of rat salivary gland tissue repair by basic fibroblast growth factor. Arch. Oral. Biol. 2000, 45:911-919.
38. Nakamura T., Hara Y., Tagawa M., Tamura M., Yuge T., Fukuda H., et al. Recombinant human basic fibroblast growth factor accelerates fracture healing by enhancing callus remodeling in experimental dog tibial fracture. J. Bone Miner. Res. 1998, 13:942-949. 10.1359/jbmr.1998.13.6.942.
39. Iwakura A., Tabata Y., Tamura N., Doi K., Nishimura K., Nakamura T., et al. Gelatin sheet incorporating basic fibroblast growth factor enhances healing of devascularized sternum in diabetic rats. Circulation 2001, 104:I325-I329.
40. Rubin J.S., Osada H., Finch P.W., Taylor W.G., Rudikoff S., Aaronson S.A. Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 1989, 86:802-806.
41. Werner S., Peters K.G., Longaker M.T., Fuller-Pace F., Banda M.J., Williams L.T. Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:6896-6900.
42. Werner S., Smola H., Liao X., Longaker M.T., Krieg T., Hofschneider P.H., et al. The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. Science 1994, 266:819-822.
43. Peters K., Werner S., Liao X., Wert S., Whitsett J., Williams L. Targeted expression of a dominant negative FGF receptor blocks branching morphogenesis and epithelial differentiation of the mouse lung. EMBO J. 1994, 13:3296-3301.
44. Guo L., Degenstein L., Fuchs E. Keratinocyte growth factor is required for hair development but not for wound healing. Genes Dev. 1996, 10:165-175.
45. Yamasaki M., Miyake A., Tagashira S., Itoh N. Structure and expression of the rat mRNA encoding a novel member of the fibroblast growth factor family. J. Biol. Chem. 1996, 271:15918-15921.
46. Beer H.D., Florence C., Dammeier J., McGuire L., Werner S., Duan D.R. Mouse fibroblast growth factor 10: cDNA cloning, protein characterization, and regulation of mRNA expression. Oncogene 1997, 15:2211-2218. 10.1038/sj.onc.1201383.
47. Ohuchi H., Shibusawa M., Nakagawa T., Ohata T., Yoshioka H., Hirai Y., et al. A chick wingless mutation causes abnormality in maintenance of Fgf8 expression in the wing apical ridge, resulting in loss of the dorsoventral boundary. Mech. Dev. 1997, 62:3-13. S092547739600634X (pii).
48. Bellusci S., Grindley J., Emoto H., Itoh N., Hogan B.L. Fibroblast growth factor 10 (FGF10) and branching morphogenesis in the embryonic mouse lung. Development 1997, 124:4867-4878.
49. Sekine K., Ohuchi H., Fujiwara M., Yamasaki M., Yoshizawa T., Sato T., et al. Fgf10 is essential for limb and lung formation. Nat. Genet. 1999, 21:138-141. 10.1038/5096.
50. Ohuchi H., Hori Y., Yamasaki M., Harada H., Sekine K., Kato S., et al. FGF10 acts as a major ligand for FGF receptor 2 IIIb in mouse multi-organ development. Biochem. Biophys. Res. Commun. 2000, 277:643-649. S0006-291X(00)93721-5 (pii). 10.1006/bbrc.2000.3721.
51. Danopoulos S., Parsa S., Al Alam D., Tabatabai R., Baptista S., Tiozzo C., et al. Transient Inhibition of FGFR2b-ligands signaling leads to irreversible loss of cellular (-catenin organization and signaling in AER during mouse limb development. PLoS ONE 2013, 8:e76248. 10.1371/journal.pone.0076248.
52. Parsa S., Kuremoto K., Seidel K., Tabatabai R., Mackenzie B., Yamaza T., et al. Signaling by FGFR2b controls the regenerative capacity of adult mouse incisors. Development 2010, 137:3743-3752. 137/22/3743 (pii). 10.1242/dev.051672.
53. Parsa S., Ramasamy S.K., De Langhe S., Gupte V.V., Haigh J.J., Medina D., et al. Terminal end bud maintenance in mammary gland is dependent upon FGFR2b signaling. Dev Biol 2008, 317:121-131. S0012-1606(08)00110-3 (pii). 10.1016/j.ydbio.2008.02.014.
54. Tai C.C., Curtis J.L., Sala F.G., Del Moral P.M., Chokshi N., Kanard R.J., et al. Induction of fibroblast growth factor 10 (FGF10) in the ileal crypt epithelium after massive small bowel resection suggests a role for FGF10 in gut adaptation. Dev. Dyn. 2009, 238:294-301. 10.1002/dvdy.21667.
55. El Agha E., Al Alam D., Carraro G., MacKenzie B., Goth K., De Langhe S.P., et al. Characterization of a novel fibroblast growth factor 10 (Fgf10) knock-in mouse line to target mesenchymal progenitors during embryonic development. PLoS ONE 2012, 7:e38452. 10.1371/journal.pone.0038452.
56. El Agha E., Herold S., Al Alam D., Quantius J., MacKenzie B., Carraro G., et al. Fgf10-positive cells represent a progenitor cell population during lung development and postnatally. Development 2014, 141:296-306. 10.1242/dev.099747.
57. Haan N., Goodman T., Najdi-Samiei a., Stratford C.M., Rice R., El Agha E., et al. Fgf10-expressing tanycytes add new neurons to the appetite/energy-balance regulating centers of the postnatal and adult hypothalamus. J. Neurosci. 2013, 33:6170-6180. 10.1523/JNEUROSCI.2437-12.2013.
58. Hajihosseini M.K., De Langhe S., Lana-Elola E., Morrison H., Sparshott N., Kelly R., et al. Localization and fate of Fgf10-expressing cells in the adult mouse brain implicate Fgf10 in control of neurogenesis. Mol. Cell Neurosci. 2008, 37:857-868. S1044-7431(08)00022-5 (pii). 10.1016/j.mcn.2008.01.008.
59. Van Vliet P., Goumans M.-J., Doevendans P.A., Sluijter J.P.G. Human cardiomyocyte progenitor cells: a short history of nearly everything. J. Cell Mol. Med. 2012, 16:1669-1673. 10.1111/j.1582-4934.2012.01535.x.
60. Hotta Y., Sasaki S., Konishi M., Kinoshita H., Kuwahara K., Nakao K., et al. Fgf16 is required for cardiomyocyte proliferation in the mouse embryonic heart. Dev. Dyn. 2008, 237:2947-2954. 10.1002/dvdy.21726.
61. Lavine K.J., Yu K., White A.C., Zhang X., Smith C., Partanen J., Endocardial, Epicardial Derived F.G.F., et al. Signals Regulate Myocardial Proliferation and Differentiation In Vivo. Dev. Cell 2005, 8:85-95. 10.1016/j.devcel.2004.12.002.
62. Kelly R.G., Brown N.A., Buckingham M.E. The arterial pole of the mouse heart forms from Fgf10-expressing cells in pharyngeal mesoderm. Dev. Cell 2001, 1:435-440. S1534-5807(01)00040-5 (pii).
63. Vega-Hernández M., Kovacs A., De Langhe S., Ornitz D.M. FGF10/FGFR2b signaling is essential for cardiac fibroblast development and growth of the myocardium. Development 2011, 138:3331-3340. 10.1242/dev.064410.
64. Marguerie A., Bajolle F., Zaffran S., Brown N.a., Dickson C., Buckingham M.E., et al. Congenital heart defects in Fgfr2-IIIb and Fgf10 mutant mice. Cardiovasc. Res. 2006, 71:50-60. 10.1016/j.cardiores.2006.03.021.
65. Rochais F., Sturny R., Chao C.-M., Mesbah K., Bennett M., Mohun T.J., et al. FGF10 promotes regional foetal cardiomyocyte proliferation and adult cardiomyocyte cell-cycle re-entry. Cardiovasc. Res. 2014, 104:432-442. 10.1093/cvr/cvu232.
66. N. Rubin, A. Darehzereshki, S. Bellusci, V. Kaartinen, C.L. Lien, FGF10 Signaling enhances epicardial cell expansion during neonatal mouse heart repair, J. Cardiovasc. Dis. Diagn. 1 (2013) 1-9, doi:10.4172/jcdd.1000101.
67. Engel F.B., Hsieh P.C.H., Lee R.T., Keating M.T. FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:15546-15551. 10.1073/pnas.0607382103.
68. Meighan-Mantha R.L., Hsu D.K.W., Guo Y., Brown S.A.N., Feng S-LY, Peifley K.A., et al. The Mitogen-inducible Fn14 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration. J. Biol. Chem. 1999, 274:33166-33176. 10.1074/jbc.274.46.33166.
69. Novoyatleva T., Sajjad A., Pogoryelov D., Patra C., Schermuly R.T., Engel F.B. FGF1-mediated cardiomyocyte cell cycle reentry depends on the interaction of FGFR-1 and Fn14. FASEB J. 2014, 28:2492-2503. 10.1096/fj.13-243576.
70. Rosenblatt-velin N., Lepore M.G., Cartoni C., Beermann F. FGF-2 controls the differentiation of resident cardiac precursors into functional cardiomyocytes. J. Clin. Invest. 2005, 115:1724-1733. 10.1172/JCI23418DS1.
71. Fon Tacer K., Bookout A.L., Ding X., Kurosu H., John G.B., Wang L., et al. Research resource: comprehensive expression atlas of the fibroblast growth factor system in adult mouse. Mol. Endocrinol. 2010, 24:2050-2064. 10.1210/me.2010-0142.
72. Barrios R., Pardo A., Ramos C., Montaño M., Ramirez R., Selman M. Upregulation of acidic fibroblast growth factor during development of experimental lung fibrosis. Am. J. Physiol. 1997, 273:L451-L458.
73. Ramos C., Montaño M., Becerril C., Cisneros-Lira J., Barrera L., Ruíz V., et al. Acidic fibroblast growth factor decreases alpha-smooth muscle actin expression and induces apoptosis in human normal lung fibroblasts. Am. J. Physiol. Lung Cell Mol. Physiol. 2006, 291:L871-L879. 10.1152/ajplung.00019.2006.
74. Ramos C., Becerril C. FGF-1 reverts epithelial-mesenchymal transition induced by TGF-β1 through MAPK/ERK kinase pathway. Am. J. Physiol. Lung Cell Mol. Physiol. 2010, 229:222-231. 10.1152/ajplung.00070.2010.
75. L. Xiao, Y. Du, Y. Shen, Y. He, H. Zhao, Z. Li, TGF-beta 1 induced fibroblast proliferation is mediated by the FGF-2/ERK pathway, Front. Biosci. (Landmark Ed.) 17 (2012) 2667-2674.
76. Ju W., Zhihong Y., Zhiyou Z., Qin H., Dingding W., Li S., et al. Inhibition of α-SMA by the ectodomain of FGFR2c attenuates lung fibrosis. Mol. Med. 2012, 18:992-1002. 10.2119/molmed.2011.00425.
77. Guzy R.D., Stoilov I., Elton T.J., Mecham R.P., Ornitz D.M. Fibroblast growth factor 2 is required for epithelial recovery, but not for pulmonary fibrosis, in response to bleomycin. Am. J. Respir Cell Mol. Biol. 2015, 52:116-128. 10.1165/rcmb.2014-0184OC.
78. Leslie C.C., McCormick-Shannon K., Mason R.J. Heparin-binding growth factors stimulate DNA synthesis in rat alveolar type II cells. Am. J. Respir Cell Mol. Biol. 1990, 2:99-106. 10.1165/ajrcmb/2.1.99.
79. Li P., Oparil S., Sun J.-Z., Thompson J.A., Chen Y.-F. Fibroblast growth factor mediates hypoxia-induced endothelin-- a receptor expression in lung artery smooth muscle cells. J. Appl. Physiol. 2003, 95:643-651. (discussion 863). 10.1152/japplphysiol.00652.2002.
80. Benisty J.I., McLaughlin V.V., Landzberg M.J., Rich J.D., Newburger J.W., Rich S., et al. Elevated basic fibroblast growth factor levels in patients with pulmonary arterial hypertension. Chest 2004, 126:1255-1261. 10.1378/chest.126.4.1255.
81. Izikki M., Guignabert C., Fadel E., Humbert M., Tu L., Zadigue P., et al. Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents. J. Clin. Invest. 2009, 119:512-523. 10.1172/JCI35070.
82. Tu L., Dewachter L., Gore B., Fadel E., Dartevelle P., Simonneau G., et al. Autocrine fibroblast growth factor-2 signaling contributes to altered endothelial phenotype in pulmonary hypertension. Am. J. Respir Cell Mol. Biol. 2011, 45:311-322. 10.1165/rcmb.2010-0317OC.
83. Ricard N., Tu L., Le Hiress M., Huertas A., Phan C., Thuillet R., et al. Increased pericyte coverage mediated by endothelial-derived fibroblast growth factor-2 and interleukin-6 is a source of smooth muscle-like cells in pulmonary hypertension. Circulation 2014, 129:1586-1597. 10.1161/CIRCULATIONAHA.113.007469.
84. Kim J., Kang Y., Kojima Y., Lighthouse J.K., Hu X., Aldred M.A., et al. An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension. Nat. Med. 2013, 19:74-82. 10.1038/nm.3040.
85. Frank L. Protective effect of keratinocyte growth factor against lung abnormalities associated with hyperoxia in prematurely born rats. Biol. Neonate 2003, 83:263-272. 10.1159/000069480.
86. Plantier L., Marchand-Adam S., Antico V.G., Boyer L., De Coster C., Marchal J., et al. Keratinocyte growth factor protects against elastase-induced pulmonary emphysema in mice. Am. J. Physiol. Lung Cell Mol. Physiol. 2007, 293:L1230-L1239. 10.1152/ajplung.00460.2006.
87. Yildirim A.O., Muyal V., John G., Müller B., Seifart C., Kasper M., et al. Palifermin induces alveolar maintenance programs in emphysematous mice. Am. J. Respir. Crit. Care Med. 2010, 181:705-717. 10.1164/rccm.200804-573OC.
88. Benjamin J.T., Smith R.J., Halloran B.A., Day T.J., Kelly D.R., Prince L.S. FGF-10 is decreased in bronchopulmonary dysplasia and suppressed by Toll-like receptor activation. Am. J. Physiol. Lung Cell Mol. Physiol. 2007, 292:L550-L558. 10.1152/ajplung.00329.2006.
89. Gupte V.V., Ramasamy S.K., Reddy R., Lee J., Weinreb P.H., Violette S.M., et al. Overexpression of fibroblast growth factor-10 during both inflammatory and fibrotic phases attenuates bleomycin-induced pulmonary fibrosis in mice. Am. J. Respir. Crit. Care Med. 2009, 180:424-436. 200811-1794OC (pii). 10.1164/rccm.200811-1794OC.
90. Klar J., Blomstrand P., Brunmark C., Badhai J., Hakansson H.F., Brange C.S., et al. Fibroblast growth factor 10 haploinsufficiency causes chronic obstructive pulmonary disease. J. Med. Genet. 2011, 48:705-709. jmedgenet-2011-100166 (pii). 10.1136/jmedgenet-2011-100166.
91. Volckaert T., Dill E., Campbell A., Tiozzo C., Majka S., Bellusci S., et al. Parabronchial smooth muscle constitutes an airway epithelial stem cell niche in the mouse lung after injury. J. Clin. Invest. 2011, 121:4409-4419. 58097 (pii). 10.1172/JCI58097.
92. McQualter J.L., Brouard N., Williams B., Baird B.N., Sims-Lucas S., Yuen K., et al. Endogenous fibroblastic progenitor cells in the adult mouse lung are highly enriched in the sca-1 positive cell fraction. Stem Cells 2009, 27:623-633. 10.1634/stemcells.2008-0866.
93. McQualter J.L., Yuen K., Williams B., Bertoncello I. Evidence of an epithelial stem/progenitor cell hierarchy in the adult mouse lung. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:1414-1419. 10.1073/pnas.0909207107.
94. McQualter J.L., McCarty R.C., Van der Velden J., O'Donoghue R.J.J., Asselin-Labat M.-L., Bozinovski S., et al. TGF-β signaling in stromal cells acts upstream of FGF-10 to regulate epithelial stem cell growth in the adult lung. Stem Cell Res. 2013, 11:1222-1233. 10.1016/j.scr.2013.08.007.
95. Hellerbrand C. Hepatic stellate cells-the pericytes in the liver. Pflugers Arch. 2013, 465:775-778. 10.1007/s00424-012-1209-5.
96. Friedman S.L., Roll F.J., Boyles J., Bissell D.M. Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proc. Natl. Acad. Sci. U.S.A. 1985, 82:8681-8685.
97. G. Carpino, A. Franchitto, S. Morini, S.G. Corradini, M. Merli, E. Gaudio, Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study, Ital. J. Anat. Embryol. 109 (2004) 225-238.
98. Steiling H., Mühlbauer M., Bataille F., Schölmerich J., Werner S., Hellerbrand C. Activated hepatic stellate cells express keratinocyte growth factor in chronic liver disease. Am. J. Pathol. 2004, 165:1233-1241. 10.1016/S0002-9440(10)63383-4.
99. Steiling H., Wüstefeld T., Bugnon P., Brauchle M., Fässler R., Teupser D., et al. Fibroblast growth factor receptor signalling is crucial for liver homeostasis and regeneration. Oncogene 2003, 22:4380-4388. 10.1038/sj.onc.1206499.
100. Tsai S.-M., Wang W.-P. Expression and function of fibroblast growth factor (FGF) 7 during liver regeneration. Cell Physiol. Biochem. 2011, 27:641-652. 10.1159/000330073.
101. Takase H.M., Itoh T., Ino S., Wang T., Koji T., Akira S., et al. FGF7 is a functional niche signal required for stimulation of adult liver progenitor cells that support liver regeneration. Genes Dev. 2013, 27:169-181. 10.1101/gad.204776.112.
102. Berg T., Rountree C.B., Lee L., Estrada J., Sala F.G., Choe A., et al. Fibroblast growth factor 10 is critical for liver growth during embryogenesis and controls hepatoblast survival via beta-catenin activation. Hepatology 2007, 46:1187-1197. 10.1002/hep.21814.
103. Antoine M., Wirz W., Tag C.G., Gressner A.M., Marvituna M., Wycislo M., et al. Expression and function of fibroblast growth factor (FGF) 9 in hepatic stellate cells and its role in toxic liver injury. Biochem. Biophys. Res. Commun. 2007, 361:335-341. 10.1016/j.bbrc.2007.06.189.
104. Schaap F.G., Leclercq I.A., Jansen P.L.M., Olde Damink S.W. Prometheus' little helper, a novel role for fibroblast growth factor 15 in compensatory liver growth. J. Hepatol. 2013, 59:1121-1123. 10.1016/j.jhep.2013.07.013.
105. Kong B., Huang J., Zhu Y., Li G., Williams J., Shen S., et al. Fibroblast growth factor 15 deficiency impairs liver regeneration in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2014, 306:G893-G902. 10.1152/ajpgi.00337.2013.
106. Padrissa-Altés S., Bachofner M., Bogorad R.L., Pohlmeier L., Rossolini T., Böhm F., et al. Control of hepatocyte proliferation and survival by Fgf receptors is essential for liver regeneration in mice. Gut 2014, 10.1136/gutjnl-2014-307874.
107. Le Moigne A., Martelly I., Barlovatz-Meimon G., Franquinet R., Aamiri A., Frisdal E., et al. Characterization of myogenesis from adult satellite cells cultured in vitro. Int. J. Dev. Biol. 1990, 34:171-180.
108. Allen R.E., Dodson M.V., Luiten L.S. Regulation of skeletal muscle satellite cell proliferation by bovine pituitary fibroblast growth factor. Exp. Cell Res. 1984, 152:154-160. 10.1016/0014-4827(84)90239-8.
109. Yablonka-Reuveni Z., Rivera A.J. Temporal expression of regulatory and structural muscle proteins during myogenesis of satellite cells on isolated adult rat fibers. Dev. Biol. 1994, 164:588-603. 10.1006/dbio.1994.1226.
110. Oliver L., Raulais D., Vigny M. Acidic fibroblast growth factor (aFGF) in developing normal and dystrophic (mdx) mouse muscles. Distribution in degenerating and regenerating mdx myofibres. Growth Factors 1992, 7:97-106.
111. Menetrey J., Kasemkijwattana C., Day C.S., Bosch P., Vogt M., Fu F.H., et al. Growth factors improve muscle healing in vivo. J. Bone Joint Surg. Br. 2000, 82:131-137.
112. Stratos I., Madry H., Rotter R., Weimer A., Graff J., Cucchiarini M., et al. Fibroblast growth factor-2-overexpressing myoblasts encapsulated in alginate spheres increase proliferation, reduce apoptosis, induce adipogenesis, and enhance regeneration following skeletal muscle injury in rats. Tissue Eng. Part. A 2011, 17:2867-2877. 10.1089/ten.tea.2011.0239.
113. Chakkalakal J.V., Jones K.M., Basson M.A., Brack A.S. The aged niche disrupts muscle stem cell quiescence. Nature 2012, 490:355-360. 10.1038/nature11438.
114. Floss T., Arnold H.H., Braun T. A role for FGF-6 in skeletal muscle regeneration. Genes Dev. 1997, 11:2040-2051.
115. Doukas J., Blease K., Craig D., Ma C., Chandler L.A., Sosnowski B.A., et al. Delivery of FGF genes to wound repair cells enhances arteriogenesis and myogenesis in skeletal muscle. Mol. Ther. 2002, 5:517-527. 10.1006/mthe.2002.0579.
116. Armand A.-S., Launay T., Pariset C., Della Gaspera B., Charbonnier F., Chanoine C. Injection of FGF6 accelerates regeneration of the soleus muscle in adult mice. Biochim. Biophys. Acta 2003, 1642:97-105.
117. Sakaue H., Konishi M., Ogawa W., Asaki T., Mori T., Yamasaki M., et al. Requirement of fibroblast growth factor 10 in development of white adipose tissue. Genes Dev. 2002, 16:908-912. 10.1101/gad.983202.
118. Asaki T., Konishi M., Miyake A., Kato S., Tomizawa M., Itoh N. Roles of fibroblast growth factor 10 (Fgf10) in adipogenesis in vivo. Mol. Cell Endocrinol. 2004, 218:119-128. 10.1016/j.mce.2003.12.017.
119. Konishi M., Asaki T., Koike N., Miwa H., Miyake A., Itoh N. Role of Fgf10 in cell proliferation in white adipose tissue. Mol. Cell Endocrinol. 2006, 249:71-77. 10.1016/j.mce.2006.01.010.
120. Ohta H., Itoh N. Roles of FGFs as adipokines in adipose tissue development, remodeling, and metabolism. Front. Endocrinol. (Lausanne) 2014, 5:18. 10.3389/fendo.2014.00018.
121. Nishimura T., Nakatake Y., Konishi M., Itoh N. Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochim. Biophys. Acta 2000, 1492:203-206.
122. Kharitonenkov A., Shiyanova T.L., Koester A., Ford A.M., Micanovic R., Galbreath E.J., et al. FGF-21 as a novel metabolic regulator. J. Clin. Invest. 2005, 115:1627-1635. 10.1172/JCI23606.
123. Suzuki M., Uehara Y., Motomura-Matsuzaka K., Oki J., Koyama Y., Kimura M., et al. betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c. Mol. Endocrinol. 2008, 22:1006-1014. 10.1210/me.2007-0313.
124. Dutchak P.A., Katafuchi T., Bookout A.L., Choi J.H., Yu R.T., Mangelsdorf D.J., et al. Fibroblast growth factor-21 regulates PPARγ activity and the antidiabetic actions of thiazolidinediones. Cell 2012, 148:556-567. 10.1016/j.cell.2011.11.062.
125. Fisher F.M., Estall J.L., Adams A.C., Antonellis P.J., Bina H.A., Flier J.S., et al. Integrated regulation of hepatic metabolism by fibroblast growth factor 21 (FGF21) in vivo. Endocrinology 2011, 152:2996-3004. 10.1210/en.2011-0281.
126. Jonker J.W., Suh J.M., Atkins A.R., Ahmadian M., Li P., Whyte J., et al. A PPAR(-FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis. Nature 2012, 485:391-394. 10.1038/nature10998.
127. Konishi M., Mikami T., Yamasaki M., Miyake A., Itoh N. Fibroblast growth factor-16 is a growth factor for embryonic brown adipocytes. J. Biol. Chem. 2000, 275:12119-12122.
128. Robson M.C., Phillips L.G., Lawrence W.T., Bishop J.B., Youngerman J.S., Hayward P.G., et al. The safety and effect of topically applied recombinant basic fibroblast growth factor on the healing of chronic pressure sores. Ann. Surg. 1992, 216:401-406. (discussion 406-408).
129. Richard J.L., Parer-Richard C., Daures J.P., Clouet S., Vannereau D., Bringer J., et al. Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot, randomized, double-blind, placebo-controlled study. Diabetes Care 1995, 18:64-69.
130. Hull M.A., Knifton A., Filipowicz B., Brough J.L., Vautier G., Hawkey C.J. Healing with basic fibroblast growth factor is associated with reduced indomethacin induced relapse in a human model of gastric ulceration. Gut 1997, 40:204-210.
131. Sellke F.W., Laham R.J., Edelman E.R., Pearlman J.D., Simons M. Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results. Ann. Thorac. Surg. 1998, 65:1540-1544.
132. Udelson J.E., Dilsizian V., Laham R.J., Chronos N., Vansant J., Blais M., et al. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 improves stress and rest myocardial perfusion abnormalities in patients with severe symptomatic chronic coronary artery disease. Circulation 2000, 102:1605-1610.
133. Fu X., Shen Z., Chen Y., Xie J., Guo Z., Zhang M., et al. Randomised placebo-controlled trial of use of topical recombinant bovine basic fibroblast growth factor for second-degree burns. Lancet 1998, 352:1661-1664. 10.1016/S0140-6736(98)01260-4.
134. Lederman R.J., Mendelsohn F.O., Anderson R.D., Saucedo J.F., Tenaglia A.N., Hermiller J.B., et al. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial. Lancet 2002, 359:2053-2058.
135. Zhang Z., Liu Y., Dou Y., Sun G., Huang Q., Guo X. The therapeutic effects of basic fibroblast growth factor injected into tympanic cavity on sensorineural deafness. Lin Chuang Er Bi Yan Hou Ke Za Zhi 2002, 16:603-604.
136. Mu J., Zhang X., Cheng J., Yuan Y. Effects of bFGF on the nasal mucosa after endoscopic sinus surgery. Lin Chuang Er Bi Yan Hou Ke Za Zhi 2005, 19:646-647.
137. Kawaguchi H., Jingushi S., Izumi T., Fukunaga M., Matsushita T., Nakamura T., et al. Local application of recombinant human fibroblast growth factor-2 on bone repair: a dose-escalation prospective trial on patients with osteotomy. J. Orthop. Res. 2007, 25:480-487. 10.1002/jor.20315.
138. Han Y., Liu J. Autologous free fat particle grafting combined with bFGF to repair facial depression. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2008, 22:339-342.
139. Yao C., Yao P., Wu H., Zha Z. Acceleration of wound healing in traumatic ulcers by absorbable collagen sponge containing recombinant basic fibroblast growth factor. Biomed. Mater. 2006, 1:33-37. 10.1088/1748-6041/1/1/005.
140. Kitamura M., Nakashima K., Kowashi Y., Fujii T., Shimauchi H., Sasano T., et al. Periodontal tissue regeneration using fibroblast growth factor-2: randomized controlled phase II clinical trial. PLoS ONE 2008, 3:e2611. 10.1371/journal.pone.0002611.
141. Hirano S., Kishimoto Y., Suehiro A., Kanemaru S., Ito J. Regeneration of aged vocal fold: first human case treated with fibroblast growth factor. Laryngoscope 2008, 118:2254-2259. 10.1097/MLG.0b013e3181845720.
142. Takehara N., Tsutsumi Y., Tateishi K., Ogata T., Tanaka H., Ueyama T., et al. Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction. J. Am. Coll. Cardiol. 2008, 52:1858-1865. 10.1016/j.jacc.2008.06.052.
143. Kawaguchi H., Oka H., Jingushi S., Izumi T., Fukunaga M., Sato K., et al. A local application of recombinant human fibroblast growth factor 2 for tibial shaft fractures: a randomized, placebo-controlled trial. J. Bone Miner. Res. 2010, 25:2735-2743. 10.1002/jbmr.146.
144. Akita S., Akino K., Yakabe A., Tanaka K., Anraku K., Yano H., et al. Basic fibroblast growth factor is beneficial for postoperative color uniformity in split-thickness skin grafting. Wound Repair Regen. 2010, 18:560-566. 10.1111/j.1524-475X.2010.00620.x.
145. Huang Y.-F., Wang L.-Q., DU G.-P., Zhang Y.-H., Ge M. The effect of recombinant bovine basic fibroblast growth factor on the LASIK-induced neurotrophic epitheliopathy and the recovery of corneal sensation after LASIK. Zhonghua Yan Ke Za Zhi 2011, 47:22-26.
146. Takagi G., Miyamoto M., Tara S., Takagi I., Takano H., Yasutake M., et al. Controlled-release basic fibroblast growth factor for peripheral artery disease: comparison with autologous bone marrow-derived stem cell transfer. Tissue Eng. Part A 2011, 17:2787-2794. 10.1089/ten.tea.2010.0525.
147. Kanemaru S.-I., Umeda H., Kitani Y., Nakamura T., Hirano S., Ito J. Regenerative treatment for tympanic membrane perforation. Otol. Neurotol. 2011, 32:1218-1223. 10.1097/MAO.0b013e31822e0e53.
148. Meduri A., Aragona P., Grenga P.L., Roszkowska A.M. Effect of basic fibroblast growth factor on corneal epithelial healing after photorefractive keratectomy. J. Refract. Surg. 2012, 28:220-223. 10.3928/1081597X-20120103-02.
149. Jiang X.-W., Zhang Y., Zhang H., Lu K., Yang S.-K., Sun G.-L. Double-blind, randomized, controlled clinical trial of the effects of diosmectite and basic fibroblast growth factor paste on the treatment of minor recurrent aphthous stomatitis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2013, 116:570-575. 10.1016/j.oooo.2013.07.003.
150. Wu J.-C., Huang W.-C., Tsai Y.-A., Chen Y.-C., Cheng H. Nerve repair using acidic fibroblast growth factor in human cervical spinal cord injury: a preliminary Phase I clinical study. J. Neurosurg. Spine 2008, 8:208-214. 10.3171/SPI/2008/8/3/208.
151. Tsai P.-Y., Cheng H., Huang W.-C., Huang M.-C., Chiu F.-Y., Chang Y.-C., et al. Outcomes of common peroneal nerve lesions after surgical repair with acidic fibroblast growth factor. J. Trauma 2009, 66:1379-1384. 10.1097/TA.0b013e3181847a63.
152. Nikol S., Baumgartner I., Van Belle E., Diehm C., Visoná A., Capogrossi M.C., et al. Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia. Mol. Ther. 2008, 16:972-978. 10.1038/mt.2008.33.
153. Belch J., Hiatt W.R., Baumgartner I., Driver I.V., Nikol S., Norgren L., et al. Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia. Lancet 2011, 377:1929-1937. 10.1016/S0140-6736(11)60394-2.
154. Kaski J.C., Consuegra-Sanchez L. Evaluation of ASPIRE trial: a Phase III pivotal registration trial, using intracoronary administration of Generx (Ad5FGF4) to treat patients with recurrent angina pectoris. Expert Opin. Biol. Ther. 2013, 13:1749-1753. 10.1517/14712598.2013.827656.
155. Spielberger R., Stiff P., Bensinger W., Gentile T., Weisdorf D., Kewalramani T., et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N. Engl. J. Med. 2004, 351:2590-2598. 10.1056/NEJMoa040125.
156. Wheeler G., Repifermin Human Genome Sciences/GlaxoSmithKline. IDrugs 2001, 4:813-819.
157. Robson M.C., Phillips T.J., Falanga V., Odenheimer D.J., Parish L.C., Jensen J.L., et al. Randomized trial of topically applied repifermin (recombinant human keratinocyte growth factor-2) to accelerate wound healing in venous ulcers. Wound Repair Regen. 2001, 9:347-352.
158. Sandborn W.J., Sands B.E., Wolf D.C., Valentine J.F., Safdi M., Katz S., et al. Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Aliment Pharmacol. Ther. 2003, 17:1355-1364.
159. Derrick T., Grillo A.O., Vitharana S.N., Jones L., Rexroad J., Shah A., et al. Effect of polyanions on the structure and stability of repifermin (keratinocyte growth factor-2). J. Pharm. Sci. 2007, 96:761-776. 10.1002/jps.20797.
160. Huang M., Berkland C. Controlled release of repifermin from polyelectrolyte complexes stimulates endothelial cell proliferation. J. Pharm. Sci. 2009, 98:268-280. 10.1002/jps.21412.
161. Wesche J., Haglund K., Haugsten E.M. Fibroblast growth factors and their receptors in cancer. Biochem. J. 2011, 437:199-213. 10.1042/BJ20101603.
162. Katoh M., Nakagama H. FGF receptors: cancer biology and therapeutics. Med. Res. Rev. 2014, 34:280-300. 10.1002/med.21288.